Abra Pradaxa

May 31st, 2018

It’s amazing what medical science can do. New medicines can sometimes it seem like magic.  But medicines are not magic.  

They need to be thoroughly tested to make sure they are not causing more harm than good.  

Case in point – Pradaxa: In 2010 the FDA approved the drug dabigatran under the brand name Pradaxa. It was approved to treat atrial fibrillaion. In 2014 it was approved for use to treat deep vein thrombosis (DVT) and pulmonary embolism (PE). But it wasn’t magic. Pradaxa had a serious side effect – internal bleeding. And doctors didn’t find a way to mitigate that condition until 2014. This complication caused bleeding of the kidneys and in the gastrointestinal system. In addition, the drug may have led to dyspepsia, further heart problems, strokes, brain hemorrhages, and deaths associated with those conditions.

Boehringer Ingelheim, Pradaxa’s manufacturer, settled thousands of class action lawsuits in 2014, paying $650 million dollars.

But just settling some lawsuits didn’t make Boehringer’s problems go away like magic. There are still some suits out there, and some that are still being filed.

If you think you are having issues because you were prescribed Pradaxa, contact us right away. If you wait too long your chances of getting justice may vanish like a rabbit into a magician’s hat. Unlike the magic the stage magician uses, the statutes of limitations can make some things vanish forever.

.

Comments

comments

Designed & Developed by sleon productions